Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
MedImmune, Inc., is a leading biotechnology company focused on researching, developing, and commercializing products to prevent or treat infectious disease, autoimmune disease, and cancer. MedImmune actively markets four products, Synagis(R) (palivizumab), FluMist(TM) (Influenza Virus Vaccine Live, Intranasal), Ethyol(R) (amifostine), and CytoGam(R) (cytomegalovirus immune globulin intravenous (human)), and has additional products in clinical testing. MedImmune employs about 1,700 people, is headquartered in Gaithersburg, Maryland, and has additional operations in Frederick, Maryland, as well as Pennsylvania, California, the United Kingdom, and the Netherlands. FluMist is manufactured by MedImmune Vaccines, Inc., and co-promoted with a division of Wyeth (NYSE: WYE). ( www.medimmune.com )
MedImmune , Inc.
One Medimmune Way
Gaithersburg, Maryland 20878
USA
Tel: (301) 398-0000
Fax: (301) 527-4200